Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).

Donata von Reibnitz,Fauzia Shaikh,Abraham J Wu, Gregory C Treharne,Rosalind Dick-Godfrey,Amanda Foster,Kaitlin M Woo,Weiji Shi, Zhigang Zhang,Shaun U Din,Daphna Y Gelblum,Ellen D Yorke,Kenneth E Rosenzweig,Andreas Rimner

Acta oncologica (Stockholm, Sweden)（2018）

Cited 50|Views38

No score

Abstract

SBRT compared to CONV is associated with improved LF rates and OS. Our data supports the continued use and expansion of SBRT as the standard of care treatment for inoperable early-stage NSCLC.

Translated text

Key words

stereotactic body radiation therapy,radiation therapy,cell lung cancer,non-small

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined